glp-1 drug novo nordisk Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say The GLP-1 Race - VERUS

Description

Even modest weight loss dramatically reduces the cytokine output from adipose tissue

100 This randomized placebo-controlled trial included 5380 patients and had a median follow-up of 18 months

Liraglutide, a member of the GLP-1RAs family, has been demonstrated to downregulate bone morphogenetic protein 4 (BMP4) expression in colorectal cancer (CRC) cells

10.2337/dc08-1984 41 DeFronzoR

While other articles simply called for more studies to further evaluate different gastric emptying assessment tools, some articles are more specific in denoting the need for more well-designed, appropriately powered clinical studies identifying the most suitable discontinuation timing and intervals, the effect of dose ranges and their specific half-lives, and duration of their effects and how they may interact with other variables (Oprea et al